Antidepressant agents: From tricyclics to serotonin uptake inhibitors

Psychological Medicine

Volumn 28, Issue 5, 1998, Pages 1169-1178

  Garattini, S ^a   Barbui, C ^a   Saraceno, B ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMINEPTINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MONOAMINE; NOMIFENSINE; NORADRENALIN; NORTRIPTYLINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; ENDOGENOUS DEPRESSION; HEART ARRHYTHMIA; HUMAN; META ANALYSIS; METHODOLOGY; MONOAMINERGIC SYSTEM; NONHUMAN; ORTHOSTATIC HYPOTENSION; QUALITY CONTROL; SUICIDE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; DRUG APPROVAL; DRUG COSTS; DRUGS, INVESTIGATIONAL; ETHICS, MEDICAL; HEALTH CARE COSTS; HUMANS; PLACEBOS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 0031687572     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291798007090     Document Type: Article

References (99)

1. Adell, A. & Artigas, F. (1991). Differential effects of clomipramine given locally or systematically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Archives of Pharmacology 343, 237-244.
2. Altamura, A. C., De Novellis, F., Guercetti, G., Invernizzi, G., Percudani, M. & Montgomery, S. A. (1989). Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. International Journal of Clinical Pharmacology Research 9, 391-396.
3. Anderson, I. M. & Tomenson, B. M. (1994). The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Journal of Psychopharmacology 8, 238-249.
4. Anderson, I. M. & Tomenson, B. M. (1995). Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal 310, 1433-1438.
5. Angst, J., Delini-Stula, A. & Stabl, M. (1993). Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis. Human Psychopharmacology 8, 311-317.
6. Anstey, K. & Brodaty, H. (1995). Antidepressants and the elderly: double-blind trials 1987-1992. International Journal of Geriatric Psychiatry 10, 265-279.
7. Banerjee, S. P., Kung, L. S., Riggi, S. J. & Chanda, S. K. (1977). Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature 268, 455-456.
8. Barbui, C. & Garattini, S. (1997). Tryptophan and depression. Lancet 349, 1553.
9. Beasley, C. M. J., Dornseif, B. E., Bosomworth, J. C., Sayler, M. E., Rampey, A. H., Heiligenstein, J. H., Thompson, V. L., Murphy, D. J. & Masica, D. N. (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 303, 685-692.
10. Bentkover, J. D. & Feighner, J. P. (1995). Cost analysis of paroxetine versus imipramine in major depression. PharmacoEconomics 8, 223-232.
11. Bergstrom, D. A. & Kellar, J. K. (1979). Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. Journal of Pharmacology and Experimental Therapeutics 209, 256-261.
12. Beuzen, J. N., Ravily, V. F., Souetre, E. J. & Thomander, L. (1993). Impact of fluoxetine on work loss in depression. International Clinical Psychopharmacology 8, 319-321.
13. Blier, P., de Montigny, C. & Chaput, Y. (1990). A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. Journal of Clinical Psychiatry 51 (suppl.), 14-20.
14. Blier, P. & de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 15, 220-226.
15. Borsini, F. (1995). Role of the serotonergic system in the forced swimming test. Neuroscience Behaviour Reviews 19, 377-395.
16. Borsini, F., Lecci, A., Mancinelli, A., D'Aranno, V. & Meli, A. (1988). Stimulation of dopamine D-2 but not D-1 receptors reduced immobility time of rats in the forced swimming test: implication or antidepressant activity. European Journal of Pharmacology 148, 301-307.
17. Byerley, W. F., McConnell, E. J., McCabe, R. T., Dawson, T. M., Grosser, B. I. & Wamsley, J. K. (1987). Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex. Brain Research 421, 377-381.
18. Cassidy, S. & Henry, J. (1987). Fatal toxicity of antidepressant drugs in overdose. British Medical Journal of Clinical Research 295, 1021-1024.
19. Ceci, A., Garattini, S., Gobbi, M. & Mennini, T. (1986). Effect of long-term amineptine treatment on pre- and post-synaptic mechanism in rat brain. British Journal of Pharmacology 88, 269-275.
20. Cervo, L. & Samanin, R. (1987). Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropsycholpharmacology 26, 1469-1472.
21. Cervo, L. & Samanin, R. (1988). Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanism in the nucleus accumbens. Journal of Pharmacy Pharmacology 40, 155-156.
22. Cervo, L., Grignaschi, G. Rossi, C. & Samanin, R. (1991). Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. European Journal of Pharmacology 196, 217-222.
23. Claghorn, J. L. & Feighner, J. P. (1993). A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. Journal of Clinical Psychopharmacology 13, 23S-27S.
24. Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M. & Lautin, A. (1990). Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. Journal of Clinical Psychiatry 51 (suppl. B), 28-33.
25. Consensus Committee (1993). Guidelines for treating depressive illness with antidepressants: a statement from the British Association of Psychopharmacology. Journal of Psychopharmacology 7, 19-23.
26. Cooper, G. L. (1988). The safety of fluoxetine. An update. British Journal of Psychiatry 153, 77-86.
27. Costa, E., Garattini, S. & Valzelli, L. (1960). Interactions between reserpine, chlorpromazine, and imipramine. Experientia 16, 461-463.
28. Danish University Antidepressant Group (1986). Citalopram: clinical effect profile in comparison with clomipramine. Psychopharmacology 90, 131-138.
29. Danish University Antidepressant Group (1990). Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders 18, 289-299.
30. de Montigny, C. & Aghajaman, G. K. (1978). Tricyclic antidepressants: long-term treatment increases responsitivity of rat forebrain neurons to serotonin. Science 202, 1303-1306.
31. Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H. & Heninger, G. R. (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry 47, 411-418.
32. Delgado, P. L., Miller, H. L., Salomon, R. M., Licinio, J., Heninger, G. R., Gelemberg, A. J. & Charney, D. S. (1993). Alpha-methylpara-tyrosine (AMPT) depletion of catecholamines in treated depressed patients. Society of Neuroscience Abstracts 19, 1868-1860.
33. Dunner, D. L., Cohn, J. B., Walshe, T., Cohn, C. K., Feighner, J. P., Fieve, R. R., Halikas, J. P., Hartford, J. T., Hearst, E. D., Settle, E. C., Menolascino, F. J. & Muller, D. J. (1992). Two combined, multicenter double-blind studies of paroxetin and doxepin in geriatric patients with major depression. Journal of Clinical Psychiatry 53 (suppl.), 57-60.
34. Edwards, J. G. (1995). Suicide and antidepressants. British Medical Journal 310, 205-206.
35. Fedoroff, J. P. & Robinson, R. G. (1989). Tricyclic antidepressants in the treatment of poststroke depression. Journal of Clinical Psychiatry 50 (suppl.), 18-23.
36. Feighner, J. P. & Cohn, J. B. (1985). Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. Journal of Clinical Psychiatry 46, 20-25.
37. Fish, C. (1985). Effect of fluoxetine on the electrocardiogram. Journal of Clinical Psychiatry 46, 42-44.
38. Fontaine, R. (1991). The efficacy and safety off sertraline versus imipramine in out-patients with major depression: a six month double-blind, parallel multicenter study. European Neuropsychopharmacology 1, 70-75.
39. Freemantle, N., House, A., Song, F., Mason, J. M. & Sheldon, T. A. (1994). Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. British Medical Journal 309, 249-253.
40. Garattini, S. (1997). Financial interests constrain drug development. Science 275, 287.
41. Garattini, S. & Samanin, R. (1988). Biochemical hypothesis on antidepressant drugs: a guide for clinicians or a toy for pharmacologists? Psychological Medicine 18, 287-304.
42. Garattini, S. & Mennini, T. (1989). Pharmacology of amineptine: synthesis and updating. Clinical Neuropharmacology 12, 13-18.
43. Georgotas, A., McCue, R. E., Friedman, E. & Cooper, T. B. (1987). Response of depressive symptoms to nortriptyline, phenelzine and placebo. British Journal of Psychiatry 151, 102-106.
44. Glassman, A. H., Roose, S. P. & Bigger, J. T. J. (1993). The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. Journal of the American Medical Association 269, 2673-2675.
45. Glowinski, J. & Axelrod, J. (1964). Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204, 1318-1319.
46. Guillibert, E., Pelicier, Y., Archanbault, J. C., Chabannes, J. P., Clerc, G., Desvilles, M., Guibert, M., Pagot, R., Poisat, J. L. & Thobie, Y. (1989). A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatrica Scandinavica 80 (suppl.), 132-134.
47. Hall, H. & Ogren, S. O. (1981). Effects of antidepressant drugs on different receptors in the brain. European Journal of Pharmacology 70, 393-407.
48. Halper, J. P. & Mann, J. J. (1988). Cardiovascular effects of antidepressant medications. British Journal of Psychiatry 153, (suppl.), 87-98.
49. Harris, M. G. & Benfield, P. (1995). Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs and Aging 6, 64-84.
50. Henry, J. A., Alexander, C. A. & Sener, E. K. (1995). Relative mortality from overdose of antidepressants. British Medical Journal 310, 215-218.
51. Hjorth, S. (1993). Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT rauptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. Journal of Neurochemistry 60, 776-779.
52. Hotopf, M., Lewis, G. & Normand, C. (1996). Are SSRIs a cost-effective alternative to tricyclics? British Journal of Psychiatry 168, 404-409.
53. Hotopf, M., Lewis, G. & Normand, C. (1997a). Putting trials on trial - the costs and the consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health 51, 354-358.
54. Hotopf, M., Hardy, R. & Lewis, G. (1997b). Discontinuation rates of SSRI and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 170, 120-127.
55. Invernizzi, R., Belli, S. & Samanin, R. (1992). Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Research 584, 322-324.
56. Invernizzi, R., Bramante, M. & Samanin, R. (1995). Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Research 696, 62-66.
57. Invernizzi, R., Bramante, M. & Samanin, R. (1996). Role of 5-HT1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacology and Biochemical Behaviour 54, 143-147.
58. Itoh, Y., Oishi, R., Nishibori, M. & Saeki, K. (1990). In vivo measurements of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism. Journal of Pharmacology Experimental Therapeutics 255, 1090-1097.
59. Jick, S. S., Dean, A. D. & Jick, H. (1995). Antidepressants and suicide. British Medical Journal 310, 215-218.
60. Joffe, R., Sokolov, S. & Streiner, D. (1996). Antidepressant treatment of depression. A meta-analysis. Canadian Journal of Psychiatry 41, 613-616.
61. Johnson, A. M. (1991). The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In Selective Serotonin Re-uptake Inhibitors (ed. J. P. Feighner and W. F. Boyer), pp. 37-70. Wiley: Chichester.
62. Jonsson, B. & Bebbington, P. E. (1994). What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry 164, 665-673.
63. Kennedy, S. H. & Bagby, R. M. (1996). Efficacy and effectiveness in the antidepressant treatment of depression: beyond meta-analysis. Canadian Journal of Psychiatry 41, 609-610.
64. Koe, B. K., Weissman, A. & Welch, W. M. (1983). Sertraline, IS,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. Journal of Pharmacology and Experimental Therapeutics 226, 686-700.
65. Koe, B. K., Koch, S. W., Lebel, L. A., Minor, K. W. & Page, M. G. (1987). Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system in rat brain. European Journal of Pharmacology 141, 187-194.
66. Kreiss, D. S. & Lucki, I. (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal of Pharmacology and Experimental Therapeutics 274, 866-876.
67. Lemberger, L., Bergstrom, R. F., Wolen, R. L., Farid, N. A., Enas, G. G. & Aronoff, G. R. (1985). Fluoxetine: clinical pharmacology and physiologic disposition. Journal of Clinical Psychiatry 46, 14-19.
68. Letizia, C., Kapik, B. & Flanders, W. D. (1996). Suicidal risk during controlled clinical investigations of fluvoxamine. Journal of Clinical Psychiatry 57, 415-421.
69. McTavish, D. & Benfield, P. (1990). Clomipramine An overview of its pharmacological properties and review of its therapeutic use in obsessive compulsive disorder and panic disorders. Drugs 39, 136-153.
70. Meagher, D. & Murray, D. (1997). Depression. Lancet 349, sI17-sI120.
71. Menting, J. E. A., Honig, A., Verhey, F. R. J., Hartmans, M., Rozendaal, N., de Vet, H. C. W. & van Praag, H. M. (1996). Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. International Clinical Psychopharmacology 11, 165-175.
72. Mitchell, P. B. (1994). Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions. Adverse Drug Reaction Toxicology Review 13, 121-144.
73. Moller, H.-J. & Volz, H. P. (1996). Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs 52, 625-638.
74. Montgomery, S. A. & Kasper, S. (1995). Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology 9 (suppl. 4), 33-40.
75. Montgomery, S. A., Henry, J., McDonald, G., Dinan, T., Lader, M., Hindmarch, I., Clare, A. & Nutt, D. (1994). Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. International Clinical Psychopharmacology 9, 47-53.
76. Nelson, D. R., Thomas, D. R. & Johnson, A. M. (1989). Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatric Scandinavica 350 (suppl.), 21-23.
77. Nelson, D. R., Palmer, K. J. & Johnson, A. M. (1990). Chronic Administration of Paroxetine and Desiramine on Beta-adrenoceptors Number and Function in Rat Brain. British Association for Psychopharmacology: Cambridge.
78. Nierenberg, A. A. & McColl, R. D. (1996). Management options for refractory depression. American Journal of Medicine 101 (suppl. 6A), 47S-51S.
79. O'Brien, B. J., Novosel, S. & Torrance, G. (1995). Assessing the economic value of a new antidepressant. A willingness-to-pay approach. PharmacoEconomics 8, 34-45.
80. Pande, A. C. & Sayler, M. E. (1993). Adverse events and treatment discontinuation in fluoxetine clinical trials. International Clinical Psychopharmacology 8, 267-269.
81. Paykel, E. S. & Priest, R. G. (1992). Recognition and management of depression in general practice: consensus statement. British Medical Journal 305, 1198-1202.
82. Peroutka, S. J. & Snyder, S. H. (1980). Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210, 88-90.
83. Perry, P. J. (1996). Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 39, 1-6.
84. Pineyro, G, Deveault, L. & Blier, P., Dennis, T. & de Montigny, C. (1995a). Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain. Naunyn Schmiedebergs Archives of Pharmacology 351, 119-125.
85. Pineyro, G., Deveault, L., de Montigny, C. & Blier, P. (1995b). Effect of prolonged administration of tianeptine on the 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Archives of Pharmacology 351, 119-125.
86. Potter, W. Z., Rudorfer, M. V. & Manji, H. (1991). The pharmacologic treatment of depression. New England Journal of Medicine 325, 633-642.
87. Pratt, G. D. & Bowery, N. G. (1990). Chronic Administration of the Antidepressant Paroxetine Failed to Decrease Beta-adrenoceptor Number in Rat Cerebral Cortex Sections. British Association for Psychopharmacology: Cambridge.
88. Rutter, J. J. & Auerbach, S. B. (1993). Acute uptake inhibition increases extracellular serotonin in the rat forebrain. Journal of Pharmacology and Experimental Therapeutics 265, 1319-1324.
89. Salzman, C., Schneider, L. & Lebowitz, B. (1993). Antidepressant treatment of very old patients. American Journal of Geriatric Psychiatry 1, 21-29.
90. Sanders-Bush, E., Breeding, M., Knoth, K. & Tsutsumi, M. (1989). Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology Berlin 99, 64-69.
91. Serra, G., Argiolas, A., Klimek, V., Fadda, F. & Gessa, G. L. (1979). Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sciences 25, 415-423.
92. Simon, G. E., Vonkorff, M., Heiligenstein, J. H., Revicki, D. A., Grothaus, L., Katon, W. & Wagner, E. H. (1996). Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs. tricyclic antidepressants. Journal of the American Medical Association 275, 1897-1902.
93. Smith, K. A., Fairburn, C. G. & Cowen, P. J. (1997). Relapse of depression after rapid depletion of tryptophan. Lancet 349, 915-919.
94. Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A. & Mason, J. (1993). Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal 306, 683-687.
95. Spyraki, C. & Fibiger, H. C. (1981). Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. European Journal of Pharmacology 74, 195-206.
96. Tao, R. & Hjorth, S. (1992). Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn Schmiedebergs Archives of Pharmacology 345, 137-143.
97. Vetulani, J., Stawarz, R. J., Dingell, J. V. & Sulser, F. (1976). A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP generating system in the rat limbic forebrain. Naunyn Schmiedebergs Archives of Pharmacology 293, 109-114.
98. Wolfe, B. B., Harden, T. K. & Sporn, J. R. (1978). Presynaptic modulation of beta-adrenoceptors in rat cerebral cortex after treatment with antidepressants. Journal of Pharmacology and Experimental Therapeutics 207, 446-457.
99. Woods, S. W. & Baker, C. B. (1997). Cost-effectiveness of newer antidepressants. Current Opinion in Psychiatry 10, 95-101.